Background: SCN1A is the most clinically relevant epilepsy gene, most mutations causing Dravet syndrome (also known as severe myoclonic epilepsy of infancy or SMEI). We evaluated clinical differences, if any, between young patients with and without a SCN1A mutations and a definite clinical diagnosis of Dravet syndrome.

Early clinical features in Dravet syndrome patients with and without SCN1A mutations / Petrelli C; Passamonti C; Cesaroni E; Mei D; Guerrini R; Zamponi N; Provinciali L.. - In: EPILEPSY RESEARCH. - ISSN 0920-1211. - STAMPA. - 99 (1-2):(2012), pp. 21-27. [10.1016/j.eplepsyres.2011.10.010]

Early clinical features in Dravet syndrome patients with and without SCN1A mutations.

GUERRINI, RENZO;
2012

Abstract

Background: SCN1A is the most clinically relevant epilepsy gene, most mutations causing Dravet syndrome (also known as severe myoclonic epilepsy of infancy or SMEI). We evaluated clinical differences, if any, between young patients with and without a SCN1A mutations and a definite clinical diagnosis of Dravet syndrome.
2012
99 (1-2)
21
27
Petrelli C; Passamonti C; Cesaroni E; Mei D; Guerrini R; Zamponi N; Provinciali L.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/647743
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 24
social impact